Targeting of XIAP combined with systemic mesenchymal stem cell-mediated delivery of sTRAIL ligand inhibits metastatic growth of pancreatic carcinoma cells. [electronic resource]
Producer: 20110315Description: 2109-20 p. digitalISSN:- 1549-4918
- Animals
- Apoptosis -- physiology
- Blotting, Western
- Cell Differentiation
- Cell Line, Tumor
- Enzyme-Linked Immunosorbent Assay
- Humans
- Mesenchymal Stem Cells -- metabolism
- Mice
- Mice, Nude
- Pancreatic Neoplasms -- therapy
- TNF-Related Apoptosis-Inducing Ligand -- genetics
- X-Linked Inhibitor of Apoptosis Protein -- genetics
No physical items for this record
Publication Type: Journal Article; Research Support, Non-U.S. Gov't
There are no comments on this title.
Log in to your account to post a comment.